Search results

LAZ will back to $25 next week From my TA analyst, the support point is 23.8, I added more under that price. Will see back to its IPO in the next severl weeks. LAZ's next earning will be fantastic. LAZARD EURO Business Berlusconi, Financiers Mull An Italian Turnaround Fund...

S&P buy opinion on FLEX Flextronics (FLEX ) posted first quarter earnings per share from operations of 17 cents, vs. 14 cents, on slightly higher revenue. S&P reiterate its buy opinion. http://yahoo.businessweek.com/investor/content/jul2005/pi20050727_8442_pi004.htm

FLEX institution buy a lot today, will be bullish : http://thomson.finance.lycos.com/lycos/iwatch/cgi-bin/iw_ticker?ticker=flex

FLEX beat the expectation both EPS and Revenue. Although net income falls, it is due to restruction one time charge. Expanding business and reducing cost by switch plants to CHina and India. Strong buy at this level, Morningstar and valueline target $16 this year...

HLTH pop, add some LAZ @ 23.6 level, due to bank sector down today, LAZ down 2% with no bad news. Market overreaction. I add more shares on LAZ.

UAW hires Lazard to comb GM books JOSEPH B. WHITE AND LEE HAWKINS JR. Wall Street Journal The Globe and Mail All material copyright Bell Globemedia Publishing Inc. or its licensors. All rights reserved. DETROIT -- Under pressure from General Motors Corp. to make significant health...

correction for flex FLEX Q1 earning tomorrow, first call estimate 0.16. S&P report is 4 stars with a target $16. Morningstar gives a 4 stars with a target $16 and with selling suggestion @ $15.7. Valueline give out stronger than market consensus Q1 which is 22 cents. Pay attention tomorrow...

FLEX Q1 earning tomorrow, first call estimate 0.16. S&P report is 4 stars with a target $30. Morningstar gives a 4 stars with a fair value $30 and with selling suggestion @ $37. Valueline give out stronger than market consensus Q1 which is 22 cents. Pay attention tomorrow. My target is still $30...

Big news for FLEX after hour: http://www.forbes.com/markets/2005/07/21/ems-nokia-ericsson-0721markets17.html?partner=yahootix Credit Suisse First Boston said strong second-quarter results from Ericsson (nasdaq: ERICY - news - people ) and Nokia (nyse: NOK - news - people ) are a positive...

NGPS almost $34, REGN $9.8, I call REGN $8.9 two weeks ago. Now FLEX July 26 earning, the valueline estimate beat the market consensus, I bet FLEX's earning will beat the expectation. Target $20

ACN report http://biz.yahoo.com/fool/050719/112179072914.html?.v=1 Pay attention to PAYX, RECN, RHI recent jump on the global outsourcing business expansion. ACN is one of the largest outsourcing services firms in US, this stock will follow the sector trend. My target is $30 for this one.

Versatel Finally Bought, Tele2 Pays EUR1.3B By Arent Jan Hesselink " Morgan Stanley & Co (MDW) Limited acts as financial advisor to Tele2, ABN Amro Holding NV (ABN) was advisor to Apax and Versatel was advised by Lazard (LAZ). " Lazard's Euro M&A business.

SCH on fire. Strong Earning and positive guidance

FLEX strong buy. Target $20 end of 2005. Will see appreciation recently with its earning soon this month. Market Concensus 0.16, but valueline gave out their estimate 0.18 due to the Nortel contract. Flextronics earned $0.16 a share in the fiscal fourth quarter (ended March 31st). The top...

FLEX strong buy. Target $20 end of 2005. Will see appreciation recently with its earning soon this month. Market Concensus 0.16, but valueline gave out their estimate 0.18 due to the Nortel contract. Flextronics earned $0.16 a share in the fiscal fourth quarter (ended March 31st). The top...

Regeneron Pharmaceuticals Attend July 22th Obesity Drug Development Summit http://www.cbinet.com/show_conference.cfm?confCode=HB549&field=daytwo In Vivo Target Discovery and Validation by High Throughput Genome Engineering A high throughput genome engineering technology platform has been...

THis is why LAZ worth at least $26.5 Take a look at this link and you will know why LAZ target is $26.5. However my target is not just based on these analyst opinion, but from FA my model. http://finance.yahoo.com/q/ao?s=LAZ Article from WJS: U.S. deal makers still lead the M&A world...

Holding ADBE to $30. REGN target $15 and LAZ target $26.5. SOLD SCHN above $27 today. Holding OS.

LAZ head to its IPO $25. Target $26.5 in the next couple of weeks. TA looks attractive. SCHN target above $30. OS target $20. ADBE target $30. HLTH target $12-$15. RHAT target $16

REGN target $15 with its new research (side effect) on eye disease. FA is ranked above B+ by valueLine and $25 target by 2008. REGN's cash and profit getting better and better. I am holding several thousand shares of REGN from under $9. Will see over $10 soon.